Edition:
United Kingdom

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

501.20INR
11:20am BST
Change (% chg)

Rs-3.80 (-0.75%)
Prev Close
Rs505.00
Open
Rs508.45
Day's High
Rs518.00
Day's Low
Rs493.65
Volume
55,429
Avg. Vol
41,865
52-wk High
Rs664.00
52-wk Low
Rs435.15

Latest Key Developments (Source: Significant Developments)

India's Alembic Pharma Gets U.S. FDA Nod For Flu Capsules
6:09am BST 

June 25 (Reuters) - Alembic Pharmaceuticals Ltd ::RECEIVED US FOOD & DRUG ADMINISTRATION (USFDA) APPROVAL FOR OSELTAMIVIR PHOSPHATE CAPSULES.  Full Article

Alembic Pharmaceuticals Gets USFDA Nod For Bromfenac Ophthalmic Solution
Monday, 24 Jun 2019 

June 24 (Reuters) - Alembic Pharmaceuticals Ltd ::SAYS RECEIVED US FOOD & DRUG ADMINISTRATION (USFDA) APPROVAL FOR BROMFENAC OPHTHALMIC SOLUTION 0.09%..  Full Article

Alembic Pharmaceuticals To Consider Proposal For Issue Of NCDs On Private Placement Basis
Thursday, 6 Jun 2019 

June 6 (Reuters) - Alembic Pharmaceuticals Ltd ::TO CONSIDER PROPOSAL FOR ISSUE OF NON-CONVERTIBLE DEBENTURES ON PRIVATE PLACEMENT BASIS.  Full Article

Alembic Pharmaceuticals Gets U.S. FDA Nod For Carbidopa And Levodopa Extended-Release Tablets
Thursday, 6 Jun 2019 

June 6 (Reuters) - Alembic Pharmaceuticals Ltd ::GETS U.S. FOOD & DRUG ADMINISTRATION APPROVAL FOR CARBIDOPA AND LEVODOPA EXTENDED-RELEASE TABLETS.  Full Article

Alembic Pharmaceuticals Consol Profit Rises
Wednesday, 8 May 2019 

May 8 (Reuters) - Alembic Pharmaceuticals Ltd ::RECOMMENDED DIVIDEND OF 5.50 RUPEES PER SHARE.MARCH QUARTER CONSOL NET PROFIT AFTER TAX 1.24 BILLION RUPEES VERSUS PROFIT 937.9 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 9.27 BILLION RUPEES VERSUS 8.53 BILLION RUPEES YEAR AGO.  Full Article

Alembic Pharmaceuticals Says JV Aleor Dermaceuticals Gets EIR From USFDA
Monday, 6 May 2019 

May 6 (Reuters) - Alembic Pharmaceuticals Ltd ::SAYS JV ALEOR DERMACEUTICALS GETS EIR FROM USFDA FOR INSPECTION AT KARAKHADI FACILITY FROM FEB 4 - 8.  Full Article

India's Alembic Pharma Gets U.S. FDA Nod For Olopatadine Solution
Thursday, 2 May 2019 

May 2 (Reuters) - Alembic Pharmaceuticals Ltd ::RECEIVES USFDA APPROVAL FOR OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION USP, 0.2%.  Full Article

Alembic Pharmaceuticals Gets U.S FDA Approval For Tadalafil Tablets
Wednesday, 27 Mar 2019 

March 27 (Reuters) - Alembic Pharmaceuticals Ltd ::GETS U.S FDA APPROVAL FOR TADALAFIL TABLETS USP.  Full Article

Alembic Pharmaceuticals Gets USFDA Nod For Acetazolamide Extended-Release Capsules
Wednesday, 20 Feb 2019 

Feb 20 (Reuters) - Alembic Pharmaceuticals Ltd ::SAYS RECEIVED US FOOD & DRUG ADMINISTRATION (USFDA) APPROVAL FOR ACETAZOLAMIDE EXTENDED-RELEASE CAPSULES, 500 MG..  Full Article

Alembic Pharmaceuticals Says Orit Laboratories Receives USFDA Approval For Fenofibrate Tablets USP
Tuesday, 12 Feb 2019 

Feb 12 (Reuters) - Alembic Pharmaceuticals Ltd ::ANNOUNCES ORIT LABORATORIES LLC RECEIVES USFDA APPROVAL FOR FENOFIBRATE TABLETS USP, 54 MG AND 160 MG.  Full Article